Cell.Ai, a precision oncology company developing advanced cell and molecular profiling platforms, announced the successful completion of a CLIA-grade analytical validation study of its OncoIncytes ...

NeoGenomics will debut its PanTracer Family and unveil the Paletrra platform at ASCO 2025, advancing precision oncology ...

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease is proud to announce ...

REVEAL GENOMICS, S.L., a biotechnology company advancing precision oncology through biomarker innovation, today announced the ...

Canada holds the G7 presidency in 2025, and can provide leadership in data governance and AI innovation. A central priority ...

East Midlands-based biotechnology company N4 Pharma has formed a new senior leadership team featuring consultants in drug ...

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease is proud to announce a strategic collaboration ...

Gayle S. Jameson, M.S.N, ACNP-BC, AOCN, an oncology nurse practitioner at HonorHealth Research Institute (HRI), is a ...

As the number of space travelers is increasing through commercial missions, it becomes more important to understand how space ...

inhibitor RMC-6236 combined with chemotherapy and other targeted therapies in 3D models involving patients with KRAS-mutated pancreatic cancer—was the Phoenix-based Translational Genomics ...

10x Genomics has settled patent infringement lawsuits with a pair of rivals, Bruker and Vizgen, through settlements that could reshape competition within the emerging single-cell and spatial genomics ...

Historically, most human mpox infections have resulted from zoonotic transmission—meaning from animals to humans—and these spillovers ...